Cyrill Bussy

Overview

• Lecturer in Nanosafety, teaching for MBChB, MPharm, MSc, MRes and CDT programmes in FBMH and also for MSc Biomaterials and CDT Grpahene programmes in FSE
• Biological Safety Advisor (BSA), AV Hill Building working group, FBMH committee
• Member of the EHS working/advisory group for the National Graphene Institute
• Academic Coordinator of the public engagement activities of the CDT GRAPHENE NOWNANO
• Editor of Focus Issue on Nanosafety in 2D materials (IOP science)

Biography

After completion of an internship at the Pasteur Institute, Rabies Virus Unit, in Paris, Cyrill graduated from the University Blaise Pascal, Clermont-Ferrand, with a MSc degree in Cell & Molecular Biology (specialised in Microbiology, Parasitology-Virology). The following year he obtained a MRes degree in Biomedical Engineering (Biomaterials and Tissue engineering) from the University of Technology, Compiègne (UTC), France, working in close collaboration with the Technology Transfer Centre in Le Mans. He then pursued a PhD in Toxicology at the Radio-Toxicology Laboratory, French National Institute for Radioprotection and Nuclear Safety (IRSN), Fontenay-aux roses, France. This work was co-funded by the French Union Chamber of Mineral Waters (including Danone Group, Nestle Waters France, Neptune).

Returning to the University of Technology, Compiègne, Biomaterials Group, he started his postdoctoral training with a project investigating the biocompatibility of innovative pectin-based nanocoatings for implants and prosthesis. This industrial application-driven project was funded by the European Commission FP6 Pecticoat project (Nanobiotechnology for the coating of medical devices). He then moved to the French National Institute of Health and Medical Research (INSERM) at the Faculty of Medicine Mondor-Créteil, France. There, he evaluated how the physico-chemical properties of carbon nanotubes may influence their biological impacts on pulmonary macrophages, in the context of occupational exposure. Half of this work was performed at the Laboratoire de Physique des Solides (affiliated to CNRS), University of Paris Saclay, and also in collaboration with the CEA (IRAMIS, NIMBE Department), the European Synchrotron Radiation Facility (ID21 group) and the chemicals and advanced materials specialist group Arkema. This work was funded by the French National Research Agencyand the Nanosciences Clusterof the Ile-de-France region.

In 2010, he relocated to the UK and joined the Nanomedicine Lab, UCL School of Pharmacy, University College London, as a visiting post-doctoral scientist and was awarded a Marie Sklodowska-Curie career development Fellowship by the European Commission (FP7) in 2011 to assess the pros and cons of using carbon nanotubes for nanomedicine in the brain. Upon completion of the Marie Curie project, he joined the University of Manchester as a Lecturer in Nanosafety.